tiprankstipranks
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (HK:2502)
:2502
Hong Kong Market
Want to see HK:2502 full AI Analyst Report?

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

0 Followers

Top Page

HK:2502

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H

(2502)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
HK$0.57
▲(31.86% Upside)
Action:Reiterated
Date:05/16/26
The score is held back primarily by weakened financial performance (losses, margin compression, and a 2025 revenue decline), with additional pressure from a negative P/E that reflects negative earnings. These risks are partly offset by constructive price momentum (above key moving averages with positive MACD) and some underlying support from positive operating cash flow and moderate leverage.
Positive Factors
Operating Cash Generation
Consistent positive operating cash flow and a return to positive free cash flow in 2024–2025 indicate the business can convert sales into cash. Over 2–6 months this supports capex, working capital and debt service, providing resilience despite headline net losses and enabling strategic reinvestment.
Negative Factors
Profitability Deterioration
A shift from multi-year profitability to consecutive net losses and compressed margins is a structural concern. Sustained losses erode retained earnings, constrain reinvestment and R&D, and risk covenant pressure or restructuring, undermining long-term competitiveness if the trend persists.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating Cash Generation
Consistent positive operating cash flow and a return to positive free cash flow in 2024–2025 indicate the business can convert sales into cash. Over 2–6 months this supports capex, working capital and debt service, providing resilience despite headline net losses and enabling strategic reinvestment.
Read all positive factors

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company Description
Henan Jinyuan Hydrogenated Chemicals Co., Ltd., based in Jiyuan, China, and established in 2012, primarily focuses on the manufacturing, processing, distribution, and sale of both hydrogenated benzene-derived chemicals and various energy commoditi...
How the Company Makes Money
null...

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary
Overall financial quality is mixed. The income statement deteriorated sharply with margin compression and losses in 2024–2025 plus a revenue decline in 2025, which materially weakens fundamentals. Offsetting this, leverage appears moderate and operating cash flow remains positive, with free cash flow positive again in 2024–2025 (though volatile and down in 2025 vs. 2024).
Income Statement
28
Negative
Balance Sheet
62
Positive
Cash Flow
54
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.60B3.10B2.33B2.30B1.48B
Gross Profit30.88M71.64M148.80M285.51M142.80M
EBITDA64.12M77.03M163.47M294.84M168.50M
Net Income-33.39M-16.04M54.92M138.23M72.47M
Balance Sheet
Total Assets1.52B1.68B1.66B1.08B971.94M
Cash, Cash Equivalents and Short-Term Investments357.55M352.62M300.71M92.47M50.08M
Total Debt290.06M338.27M262.97M165.30M51.17M
Total Liabilities446.60M584.85M535.95M355.88M418.55M
Stockholders Equity951.54M985.37M1.02B573.79M457.93M
Cash Flow
Free Cash Flow72.66M13.82M-43.95M199.74M44.27M
Operating Cash Flow114.76M96.86M104.46M318.82M94.88M
Investing Cash Flow-41.12M-268.86M-71.06M-150.12M-58.70M
Financing Cash Flow-68.09M2.49M204.95M-139.06M-44.28M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.43
Price Trends
50DMA
0.57
Negative
100DMA
0.53
Positive
200DMA
0.48
Positive
Market Momentum
MACD
-0.01
Positive
RSI
43.11
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Neutral. The current price of 0.43 is below the 20-day moving average (MA) of 0.60, below the 50-day MA of 0.57, and below the 200-day MA of 0.48, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 43.11 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$1.20B8.663.36%7.85%-5.34%43.44%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
59
Neutral
HK$10.40B-23.08-3.31%3.48%3.39%-2.32%
59
Neutral
HK$11.38B3.9912.61%5.31%0.46%6.62%
56
Neutral
HK$919.80M-13.32-3.55%-16.30%-113.19%
49
Neutral
HK$1.39B-38.84-15.58%-0.05%-54.13%
48
Neutral
HK$2.59B-2.18-39.25%-9.38%-5783.70%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.55
0.17
44.74%
HK:0336
Huabao International Holdings
3.22
0.41
14.71%
HK:0408
Yip's Chemical Holdings
2.13
0.67
46.19%
HK:3318
China Boton Group Co., Ltd.
2.40
0.74
44.58%
HK:0546
Fufeng Group Limited
4.54
-2.25
-33.17%
HK:0301
SANVO Fine Chemicals Group Limited
2.95
1.55
110.71%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Hydrogenated Chemicals shareholders back AGM resolutions, skip 2025 final dividend
May 20, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported that all resolutions at its 20 May 2026 annual general meeting were approved by shareholders via poll, with 716.73 million shares voting, representing 75% of issued H shares. Shareholders end...
Henan Jinyuan Hydrogenated Chemicals Sets AGM, Cancels 2025 Final Dividend
Apr 23, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has called its 2025 annual general meeting for 20 May 2026 in Hong Kong, where shareholders will review board and supervisory committee reports, audited 2025 financial statements, and the annual repor...
Henan Jinyuan Hydrogenated Chemicals Swings to Shareholder Loss on Weaker 2025 Revenue
Mar 23, 2026
Henan Jinyuan Hydrogenated Chemicals reported 2025 revenue of RMB2.60 billion, down from RMB3.10 billion a year earlier, as gross profit narrowed sharply and joint-venture performance turned negative. The group swung to a net loss attributable to ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 16, 2026